These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Serum CEA in the follow-up of colorectal carcinoma: experience in a district general hospital.
    Author: Allen-Mersh TG.
    Journal: Ann R Coll Surg Engl; 1984 Jan; 66(1):14-6. PubMed ID: 6691692.
    Abstract:
    Serum CEA was measured at 6-monthly intervals, over a 3-year period, in 102 patients being followed up after apparently complete excision of colorectal carcinoma. Residual disease was identified in 27 patients and was preceded by a CEA rise in 22 of these patients (81.5%). The CEA was initially normal in 68% of patients with residual disease in whom it subsequently rose. Rise in CEA was not detected until a median of 14 weeks before recurrence was diagnosed clinically. CEA-instigated second-look laparotomy was performed in 7 patients (31.5% of cases with CEA-associated residual disease). Despite a high resectability rate, no patient was cured. The results might have been improved by more frequent CEA measurement and more immediate second-look laparotomy, but in this study, CEA rise was not associated with surgically curable residual disease.
    [Abstract] [Full Text] [Related] [New Search]